29/#956 Cost-effectiveness of pembrolizumab for first-line treatment in patients with persistent, recurrent, or metastatic cervical cancer in the United States
Featured Printed Posters (Poster Rounds with the Professors)(2022)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要